Biotechnology Ultrasector ProfundBIPSX
Type
Mutual fund
Peer group
Alternative
Net assets
$182.6M
Expense ratio
2.52%
1-year return
+86.2%
3 years, a year
+18.7%
5 years, a year
+9.2%
Holdings
157
What it aims to do.
Biotechnology UltraSector ProFund (the Fund) seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) of the daily performance of the S&P Biotechnology Select Industry Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| N/A | 8.47% |
| N/A | 7.20% |
| N/A | 6.35% |
| N/A | 4.24% |
| N/A | 2.11% |
| Agpxx | 2.05% |
| N/A | 1.48% |
| Apellis Pharmaceuticals Inc | 1.35% |
| RVMD Revolution Medicines Inc | 1.19% |
| TVTX Travere Therapeutics Inc | 1.17% |
More on BIPSX.
- BIPSX overview
- BIPSX holdings
- BIPSX risk
- BIPSX costs
- BIPSX money in and out
- BIPSX share classes
- Compare BIPSX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.